DNA Marker Predicts Platinum Drug Response in Breast, Ovarian Cancer
Marker identifies tumors unable to repair DNA damage by platinum agents Newswise BOSTONScientists from Brigham and Women’s Hospital and Dana-Farber Cancer Institute and their colleagues have found a...
View ArticleGenetic marker identifies tumors unable to repair DNA damage by platinum agents
Scientists from Brigham and Women’s Hospital and Dana-Farber Cancer Institute and their colleagues have found a genetic marker that predicts which aggressive “triple negative” breast cancers and...
View ArticleGenerex Biotechnology Announces Presentation of Early Results Showing...
WORCESTER, Mass.and TORONTO, Sept.13, 2012 /PRNewswire/ — Generex Biotechnology Corporation (GNBT) (www.generex.com), announced today presentation of early results from an efficacy study of an...
View ArticlePersonalized Medicine's Transformation of Healthcare Accelerates
SAN FRANCISCO, CA–(Marketwire – Oct 1, 2012) – The life sciences sector continued to outperform the broader markets in September, but developments during the month were notable for highlighting the...
View Article